Fuller & Thaler Asset Management, Inc. Emergent Bio Solutions Inc. Transaction History

Fuller & Thaler Asset Management, Inc.

$25 Billion
Q3 2024

A detailed history of Fuller & Thaler Asset Management, Inc. transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Fuller & Thaler Asset Management, Inc. holds 155,895 shares of EBS stock, worth $1.48 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

155,895

Previous 739,825 78.93%

Holding current value

$1.48 Million

Previous $5.05 Million 74.21%

% of portfolio

0.01%

Previous 0.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$5.72 - $14.77 $3.34 Million - $8.62 Million	-583,930 Reduced 78.93%	155,895 $1.3 Million
Q2 2024 Aug 09, 2024	SELL	$1.86 - $6.98 $66,588 - $249,884	-35,800 Reduced 4.62%	739,825 $5.05 Million
Q1 2024 May 13, 2024	BUY	$1.5 - $3.41 $1.16 Million - $2.64 Million	775,625 New	775,625 $1.96 Million
Q2 2021 Aug 13, 2021	SELL	$56.61 - $80.46 $28.5 Million - $40.5 Million	-503,405 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$86.23 - $125.19 $18.7 Million - $27.1 Million	216,671 Added 75.57%	503,405 $46.8 Million
Q4 2020 Feb 11, 2021	BUY	$79.17 - $111.47 $7.57 Million - $10.7 Million	95,599 Added 50.02%	286,734 $25.7 Million
Q3 2020 Nov 09, 2020	BUY	$81.91 - $134.94 $15.7 Million - $25.8 Million	191,135 New	191,135 $19.8 Million
Q2 2019 Aug 13, 2019	SELL	$39.92 - $53.86 $8 Million - $10.8 Million	-200,450 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$48.23 - $66.16 $322,321 - $442,147	6,683 Added 3.45%	200,450 $10.1 Million
Q4 2018 Feb 14, 2019	SELL	$55.63 - $73.24 $744,774 - $980,537	-13,388 Reduced 6.46%	193,767 $11.5 Million
Q3 2018 Nov 13, 2018	SELL	$52.05 - $66.51 $462,151 - $590,542	-8,879 Reduced 4.11%	207,155 $13.6 Million
Q2 2018 Aug 07, 2018	BUY	$48.33 - $55.64 $38,374 - $44,178	794 Added 0.37%	216,034 $10.9 Million
Q1 2018 May 14, 2018	SELL	$44.44 - $54.39 $284,416 - $348,096	-6,400 Reduced 2.89%	215,240 $11.3 Million
Q4 2017 Feb 12, 2018	BUY	$37.77 - $47.75 $8.37 Million - $10.6 Million	221,640	221,640 $10.3 Million

Others Institutions Holding EBS

# of Institutions

159

Shares Held

33.7M

Call Options Held

453K

Put Options Held

931K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $473M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fuller & Thaler Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Fuller & Thaler Asset Management, Inc. with notifications on news.

Account

Fuller & Thaler Asset Management, Inc. Emergent Bio Solutions Inc. Transaction History